Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNK3 | O14649 | 14/20 | 0.66 |
| ▸ | KCNK9 | Q9NPC2 | 14/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | ALPL | P05186 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18952499 | 0.91 | GAA (0.65) | KCNK3KCNK9KDM4EGAASLC2A1 | |
| SCHEMBL18963197 | 0.89 | KDM4E (0.75) | KCNK3KCNK9KDM4EGAASLC2A1 | |
| SCHEMBL22269546 | 0.89 | KCNK3 (0.66) | KCNK3KCNK9KDM4EGAASLC2A1 | |
| SCHEMBL22635913 | 0.89 | KCNK3 (0.66) | KCNK3KCNK9KDM4EGAASLC2A1 | |
| SCHEMBL21904739 | 0.87 | KDM4E (0.63) | KCNK3KCNK9KDM4EGAASLC2A1 | |
| SCHEMBL18963129 | 0.86 | KCNK3 (0.67) | KCNK3KCNK9KDM4EGAASLC2A1 | |
| SCHEMBL22269606 | 0.86 | KCNK3 (0.67) | KCNK3KCNK9KDM4EGAASLC2A1 | |
| SCHEMBL22269533 | 0.86 | KCNK3 (0.67) | KCNK3KCNK9KDM4EGAASLC2A1 | |
| SCHEMBL18952522 | 0.84 | KCNK3 (0.62) | KCNK3KCNK9KDM4EGAASLC2A1 | |
| Hydrochloric Acid SCHEMBL22260966 | 0.83 | KCNK3 (0.61) | KCNK3KCNK9KDM4EGAASLC2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025082731-A1 | INTRANASAL FORMULATIONS FOR TREATING OBSTRUCTIVE SLEEP APNEA | MOSANNA THERAPEUTICS AG (CH) | 2025-04-24 | — | — | WO | disclosed |
| EP-3386979-B1 | 2-PHENYL-3-(PIPERAZINOMETHYL)IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AS BLOCKERS OF THE TASK-1 AND TASK-2 CHANNELS FOR TREATING SLEEP-RELATED BREATHING DISORDERS | Bayer Pharma AG (DE) | 2020-07-29 | — | — | EP | disclosed |